| Authors: |
Galeano-Otero I; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.)., Dominguez-Liste B; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Asprón C; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Fernández-Chacón M; Faculty of Health Sciences, Loyola Biomedical Research Group, Department of Health and Biomedical Sciences, Universidad Loyola Andalucía, Seville, Spain (M.F.-C.)., Escacena-Izquierdo L; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Del Toro R; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Spain (M.R.-T., M.C.D.-R.).; Biomedical Research and Innovation Institute of Cadiz, Spain (M.R.-T., M.C.D.-R.)., Durán-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Spain (M.R.-T., M.C.D.-R.).; Biomedical Research and Innovation Institute of Cadiz, Spain (M.R.-T., M.C.D.-R.)., Siegfried G; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.)., Ordóñez-Fernández A; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.)., Khatib AM; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.)., Rosado JA; Department of Physiology, Institute of Molecular Pathology Biomarkers, University of Extremadura, Caceres, Spain (J.A.R.)., Smani T; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.). |
